Publikationer från Klinisk neurofysiologi

Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis The RINOMAX Randomized Clinical Trial

Piehl, Fredrik; Eriksson-Dufva, Ann; Budzianowska, Anna; Feresiadou, Amalia et al.

Ingår i JAMA Neurology, s. 1105-1112, 2022.

DOI för Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis The RINOMAX Randomized Clinical Trial

Enrichment of serum IgG4 in MuSK myasthenia gravis patients

Vergoossen, Dana L. E.; Ruiter, Annabel M.; Keene, Kevin R.; Niks, Erik H. et al.

Ingår i Journal of Neuroimmunology, 2022.

DOI för Enrichment of serum IgG4 in MuSK myasthenia gravis patients Ladda ner fulltext (pdf) av Enrichment of serum IgG4 in MuSK myasthenia gravis patients

Ultrathin Gold Microelectrode Array using Polyelectrolyte Multilayers for Flexible and Transparent Electro-Optical Neural Interfaces

Hong, Woongki; Lee, Jee Woong; Kim, Duhee; Hwang, Yujin et al.

Ingår i Advanced Functional Materials, 2022.

DOI för Ultrathin Gold Microelectrode Array using Polyelectrolyte Multilayers for Flexible and Transparent Electro-Optical Neural Interfaces

Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders

Rostedt Punga, Anna; Maddison, Paul; Heckmann, Jeannine M.; Guptill, Jeffrey et al.

Ingår i Lancet Neurology, s. 176-188, 2022.

DOI för Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders

Towards Personalized Medicine in Myasthenia Gravis: Role of Circulating microRNAs miR-30e-5p, miR-150-5p and miR-21-5p

Beretta, Francesca; Huang, Yu-Fang; Rostedt Punga, Anna

Ingår i Cells, 2022.

DOI för Towards Personalized Medicine in Myasthenia Gravis: Role of Circulating microRNAs miR-30e-5p, miR-150-5p and miR-21-5p Ladda ner fulltext (pdf) av Towards Personalized Medicine in Myasthenia Gravis: Role of Circulating microRNAs miR-30e-5p, miR-150-5p and miR-21-5p

Novel pathogenic ALG2 mutation causing congenital myasthenic syndrome: A case report

Ehrstedt, Christoffer; Liu, Wei-Wei; Frykholm, Carina; Beeson, David et al.

Ingår i Neuromuscular Disorders, s. 80-83, 2022.

DOI för Novel pathogenic ALG2 mutation causing congenital myasthenic syndrome: A case report Ladda ner fulltext (pdf) av Novel pathogenic ALG2 mutation causing congenital myasthenic syndrome: A case report

Cancer in myasthenia gravis subtypes in relation to immunosuppressive treatment and acetylcholine receptor antibodies: A Swedish nationwide register study

Verwijst, Johanna; Westerberg, Elisabet; Rostedt Punga, Anna

Ingår i European Journal of Neurology, s. 1706-1715, 2021.

DOI för Cancer in myasthenia gravis subtypes in relation to immunosuppressive treatment and acetylcholine receptor antibodies: A Swedish nationwide register study Ladda ner fulltext (pdf) av Cancer in myasthenia gravis subtypes in relation to immunosuppressive treatment and acetylcholine receptor antibodies: A Swedish nationwide register study

Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients: A prospective study

Frithiof, Robert; Rostami, Elham; Kumlien, Eva; Virhammar, Johan et al.

Ingår i Clinical Neurophysiology, s. 1733-1740, 2021.

DOI för Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients: A prospective study Ladda ner fulltext (pdf) av Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients: A prospective study

Epidemiology of Myasthenia Gravis in Sweden 2006-2016

Westerberg, Elisabet; Rostedt Punga, Anna

Ingår i Brain and Behavior, 2020.

DOI för Epidemiology of Myasthenia Gravis in Sweden 2006-2016 Ladda ner fulltext (pdf) av Epidemiology of Myasthenia Gravis in Sweden 2006-2016

Botulinum toxin injections associated with suspected myasthenia gravis: An underappreciated cause of MG-like clinical presentation

Rostedt Punga, Anna; Liik, Maarika

Ingår i Clinical Neurophysiology Practice, s. 46-49, 2020.

DOI för Botulinum toxin injections associated with suspected myasthenia gravis: An underappreciated cause of MG-like clinical presentation Ladda ner fulltext (pdf) av Botulinum toxin injections associated with suspected myasthenia gravis: An underappreciated cause of MG-like clinical presentation

Mortality rates and causes of death in Swedish Myasthenia Gravis patients

Westerberg, Elisabet; Rostedt Punga, Anna

Ingår i Neuromuscular Disorders, s. 815-824, 2020.

DOI för Mortality rates and causes of death in Swedish Myasthenia Gravis patients Ladda ner fulltext (pdf) av Mortality rates and causes of death in Swedish Myasthenia Gravis patients

Myasthenia gravis patient and physician opinions about immunosuppressant reduction

Hehir, Michael K.; Rostedt Punga, Anna; Ciafaloni, Emma

Ingår i Muscle and Nerve, s. 767-772, 2020.

DOI för Myasthenia gravis patient and physician opinions about immunosuppressant reduction

Myasthenia Gravis and Physical Exercise: A Novel Paradigm

O'Connor, Laura; Westerberg, Elisabet; Rostedt Punga, Anna

Ingår i Frontiers in Neurology, 2020.

DOI för Myasthenia Gravis and Physical Exercise: A Novel Paradigm Ladda ner fulltext (pdf) av Myasthenia Gravis and Physical Exercise: A Novel Paradigm

Flodvåg av långtidssjuka covid-19-patienter väntar

Rostedt Punga, Anna; Strömme, Maria; Alimohammadi, Mohammed; Eltahir, Mohammed et al.

Ingår i Dagens Nyheter, s. 5-5, 2020.

Estrogen Receptor, Inflammatory, and FOXO Transcription Factors Regulate Expression of Myasthenia Gravis-Associated Circulating microRNAs

Fiorillo, Alyson A.; Heier, Christopher R.; Huang, Yu-Fang; Tully, Christopher B. et al.

Ingår i Frontiers in Immunology, 2020.

DOI för Estrogen Receptor, Inflammatory, and FOXO Transcription Factors Regulate Expression of Myasthenia Gravis-Associated Circulating microRNAs Ladda ner fulltext (pdf) av Estrogen Receptor, Inflammatory, and FOXO Transcription Factors Regulate Expression of Myasthenia Gravis-Associated Circulating microRNAs

Circulating miRNAs as Potential Biomarkers in Myasthenia Gravis: Tools for Personalized Medicine

Sabre, Liis; Punga, Tanel; Rostedt Punga, Anna

Ingår i Frontiers in Immunology, 2020.

DOI för Circulating miRNAs as Potential Biomarkers in Myasthenia Gravis: Tools for Personalized Medicine Ladda ner fulltext (pdf) av Circulating miRNAs as Potential Biomarkers in Myasthenia Gravis: Tools for Personalized Medicine

miR-1933-3p is upregulated in skeletal muscles of MuSK+ EAMG mice and affects Impa1 and Mrpl27

Bogatikov, Evgenii; Lindblad, Ida; Punga, Tanel; Rostedt Punga, Anna

Ingår i Neuroscience research, s. 46-52, 2020.

DOI för miR-1933-3p is upregulated in skeletal muscles of MuSK+ EAMG mice and affects Impa1 and Mrpl27

Pattern of Habitual Physical Exercise in Myasthenia Gravis Patients

O'Connor, Laura; Westerberg, Elisabet; Rostedt Punga, Anna

Ingår i JOURNAL OF NEUROMUSCULAR DISEASES, s. 85-91, 2019.

DOI för Pattern of Habitual Physical Exercise in Myasthenia Gravis Patients

Study protocol for a randomised controlled trial with clinical, neurophysiological, laboratory and radiological outcome for surgical versus non-surgical treatment for lumbar spinal stenosis: the Uppsala Spinal Stenosis Trial (UppSten)

Pazarlis, Konstantinos A.; Rostedt Punga, Anna; Schizas, Nikos; Sandén, Bengt et al.

Ingår i BMJ Open, 2019.

DOI för Study protocol for a randomised controlled trial with clinical, neurophysiological, laboratory and radiological outcome for surgical versus non-surgical treatment for lumbar spinal stenosis: the Uppsala Spinal Stenosis Trial (UppSten) Ladda ner fulltext (pdf) av Study protocol for a randomised controlled trial with clinical, neurophysiological, laboratory and radiological outcome for surgical versus non-surgical treatment for lumbar spinal stenosis: the Uppsala Spinal Stenosis Trial (UppSten)

Cognitive dysfunction in mice with passively induced MuSK antibody seropositive myasthenia gravis

Sabre, Liis; Evoli, Amelia; Rostedt Punga, Anna

Ingår i Journal of the Neurological Sciences, s. 15-21, 2019.

DOI för Cognitive dysfunction in mice with passively induced MuSK antibody seropositive myasthenia gravis

Facing the challenges of electrodiagnostic studies in the very elderly (>80 years) population

Rostedt Punga, Anna; Jabre, Joe F.; Amandusson, Åsa

Ingår i Clinical Neurophysiology, s. 1091-1097, 2019.

DOI för Facing the challenges of electrodiagnostic studies in the very elderly (>80 years) population

miR-30e-5p as predictor of generalization in ocular myasthenia gravis

Sabre, Liis; Maddison, Paul; Wong, Sui H.; Sadalage, Girija et al.

Ingår i Annals of clinical and translational neurology, s. 243-251, 2019.

DOI för miR-30e-5p as predictor of generalization in ocular myasthenia gravis Ladda ner fulltext (pdf) av miR-30e-5p as predictor of generalization in ocular myasthenia gravis

Inflammatory and anti-inflammatory markers in plasma: from late pregnancy to early postpartum

Bränn, Emma; Edvinsson, Åsa; Rostedt Punga, Anna; Sundström Poromaa, Inger et al.

Ingår i Scientific Reports, 2019.

DOI för Inflammatory and anti-inflammatory markers in plasma: from late pregnancy to early postpartum Ladda ner fulltext (pdf) av Inflammatory and anti-inflammatory markers in plasma: from late pregnancy to early postpartum

Circulating microRNA plasma profile in MuSK plus myasthenia gravis

Sabre, Liis; Guptill, Jeffrey T.; Russo, Melissa; Juel, Vern C. et al.

Ingår i Journal of Neuroimmunology, s. 87-91, 2018.

DOI för Circulating microRNA plasma profile in MuSK plus myasthenia gravis

Advances in autoimmune myasthenia gravis management

Wang, Shuhui; Breskovska, Iva; Gandhy, Shreya; Rostedt Punga, Anna et al.

Ingår i Expert Review of Neurotherapeutics, s. 573-588, 2018.

DOI för Advances in autoimmune myasthenia gravis management

Long-Term High-Density Extracellular Recordings Enable Studies of Muscle Cell Physiology

Lewandowska, Marta; Bogatikov, Evgenii; Hierlemann, Andreas R.; Rostedt Punga, Anna

Ingår i Frontiers in Physiology, 2018.

DOI för Long-Term High-Density Extracellular Recordings Enable Studies of Muscle Cell Physiology Ladda ner fulltext (pdf) av Long-Term High-Density Extracellular Recordings Enable Studies of Muscle Cell Physiology

Circulating microRNA miR-21-5p, miR-150-5p and miR-30e-5p correlate with clinical status in late onset myasthenia gravis

Sabre, Liis; Maddison, Paul; Sadalage, Girija; Ambrose, Philip Alexander et al.

Ingår i Journal of Neuroimmunology, s. 164-170, 2018.

DOI för Circulating microRNA miR-21-5p, miR-150-5p and miR-30e-5p correlate with clinical status in late onset myasthenia gravis Ladda ner fulltext (pdf) av Circulating microRNA miR-21-5p, miR-150-5p and miR-30e-5p correlate with clinical status in late onset myasthenia gravis

Lifestyle factors and disease-specific differences in subgroups of Swedish Myasthenia Gravis

Westerberg, Elisabet; Landtblom, Anne-Marie; Rostedt Punga, Anna

Ingår i Acta Neurologica Scandinavica, s. 557-565, 2018.

DOI för Lifestyle factors and disease-specific differences in subgroups of Swedish Myasthenia Gravis

Thymectomy lowers the myasthenia gravis biomarker miR-150-5p

Molin, Carl Johan; Sabre, Liis; Weis, Cleo-Aron; Punga, Tanel et al.

Ingår i Neurology, 2018.

DOI för Thymectomy lowers the myasthenia gravis biomarker miR-150-5p Ladda ner fulltext (pdf) av Thymectomy lowers the myasthenia gravis biomarker miR-150-5p

The impact of physical exercise on neuromuscular function in Myasthenia gravis patients: A single-subject design study

Westerberg, Elisabet; Molin, Carl Johan; Spörndly-Nees, Søren; Widenfalk, Johan et al.

Ingår i Medicine, 2018.

DOI för The impact of physical exercise on neuromuscular function in Myasthenia gravis patients: A single-subject design study Ladda ner fulltext (pdf) av The impact of physical exercise on neuromuscular function in Myasthenia gravis patients: A single-subject design study

Circulating microRNAs as potential biomarkers in myasthenia gravis patients.

Rostedt Punga, Anna; Punga, Tanel

Ingår i Annals of the New York Academy of Sciences, s. 33-40, 2018.

DOI för Circulating microRNAs as potential biomarkers in myasthenia gravis patients.

High-resistance strength training does not affect nerve cross sectional area – An ultrasound study

Molin, Carl Johan; Widenfalk, Johan; Rostedt Punga, Anna

Ingår i Clinical Neurophysiology Practice, s. 163-169, 2017.

DOI för High-resistance strength training does not affect nerve cross sectional area – An ultrasound study Ladda ner fulltext (pdf) av High-resistance strength training does not affect nerve cross sectional area – An ultrasound study

Diagnostic Utility of Repetitive Nerve Stimulation in a Large Cohort of Patients With Myasthenia Gravis

Amandusson, Åsa; Elf, Kristin; Grindlund, Margareta E; Punga, Anna R.

Ingår i Journal of clinical neurophysiology, s. 400-407, 2017.

DOI för Diagnostic Utility of Repetitive Nerve Stimulation in a Large Cohort of Patients With Myasthenia Gravis

Neurophysiological Measures of Efficacy and Safety for Botulinum Toxin Injection in Facial and Bulbar Muscles: Special Considerations

Alimohammadi, Mohammed; Rostedt Punga, Anna

Ingår i Toxins, 2017.

DOI för Neurophysiological Measures of Efficacy and Safety for Botulinum Toxin Injection in Facial and Bulbar Muscles: Special Considerations Ladda ner fulltext (pdf) av Neurophysiological Measures of Efficacy and Safety for Botulinum Toxin Injection in Facial and Bulbar Muscles: Special Considerations

Diversity in mental fatigue and social profile of patients with myasthenia gravis in two different Northern European countries

Sabre, Liis; Westerberg, Elisabet; Liik, Maarika; Punga, Anna R.

Ingår i Brain and Behavior, 2017.

DOI för Diversity in mental fatigue and social profile of patients with myasthenia gravis in two different Northern European countries Ladda ner fulltext (pdf) av Diversity in mental fatigue and social profile of patients with myasthenia gravis in two different Northern European countries

Physical exercise in Myasthenia Gravis is safe and improves neuromuscular parameters and physical performance-based measures: A pilot study

Westerberg, Elisabet; Molin, Carl Johan; Lindblad, Ida; Emtner, Margareta et al.

Ingår i Muscle and Nerve, s. 207-214, 2017.

DOI för Physical exercise in Myasthenia Gravis is safe and improves neuromuscular parameters and physical performance-based measures: A pilot study

Profile of upregulated inflammatory proteins in sera of Myasthenia Gravis patients.

Molin, Carl Johan; Westerberg, Elisabet; Rostedt Punga, Anna

Ingår i Scientific Reports, 2017.

DOI för Profile of upregulated inflammatory proteins in sera of Myasthenia Gravis patients. Ladda ner fulltext (pdf) av Profile of upregulated inflammatory proteins in sera of Myasthenia Gravis patients.

Repetitive nerve stimulation often fails to detect abnormal decrement in acute severe generalized Myasthenia Gravis

Liik, Maarika; Rostedt Punga, Anna

Ingår i Clinical Neurophysiology, s. 3480-3484, 2016.

DOI för Repetitive nerve stimulation often fails to detect abnormal decrement in acute severe generalized Myasthenia Gravis

A Randomized, Comparative Study to Evaluate Efficacy and Safety of Two Injection Volumes of AbobotulinumtoxinA in Treatment of Glabellar Lines

Punga, Anna Rostedt; Alimohammadi, Mohammad; Fagrell, Dan; Nyberg, Frida et al.

Ingår i Dermatologic Surgery, s. 967-976, 2016.

DOI för A Randomized, Comparative Study to Evaluate Efficacy and Safety of Two Injection Volumes of AbobotulinumtoxinA in Treatment of Glabellar Lines

Compound Motor Action Potential: Electrophysiological Marker for Muscle Training

Molin, Carl Johan; Punga, Anna R.

Ingår i Journal of clinical neurophysiology, s. 340-345, 2016.

DOI för Compound Motor Action Potential: Electrophysiological Marker for Muscle Training

Low vitamin D levels in healthy controls and patients with autoimmune neuromuscular disorders in Greece

Chroni, Elisabeth; Dimisianos, Nikolaos; Punga, Anna Rostedt

Ingår i Acta Neurologica Belgica, s. 57-63, 2016.

DOI för Low vitamin D levels in healthy controls and patients with autoimmune neuromuscular disorders in Greece

Disease specific enrichment of circulating let-7 family microRNA in MuSK+ myasthenia gravis.

Punga, Tanel; Bartoccioni, Emanuela; Lewandowska, Marta; Damato, Valentina et al.

Ingår i Journal of Neuroimmunology, s. 21-26, 2016.

DOI för Disease specific enrichment of circulating let-7 family microRNA in MuSK+ myasthenia gravis. Ladda ner fulltext (pdf) av Disease specific enrichment of circulating let-7 family microRNA in MuSK+ myasthenia gravis.

Regional Diffusion of Botulinum Toxin in Facial Muscles: A Randomised Double-blind Study and a Consideration for Clinical Studies with Split-face Design

Punga, Anna Rostedt; Eriksson, Annika; Alimohammadi, Mohammad

Ingår i Acta Dermato-Venereologica, s. 948-951, 2015.

DOI för Regional Diffusion of Botulinum Toxin in Facial Muscles: A Randomised Double-blind Study and a Consideration for Clinical Studies with Split-face Design Ladda ner fulltext (pdf) av Regional Diffusion of Botulinum Toxin in Facial Muscles: A Randomised Double-blind Study and a Consideration for Clinical Studies with Split-face Design

Disease specific signature of circulating miR-150-5p and miR-21-5p in myasthenia gravis patients

Punga, Anna Rostedt; Andersson, Mats; Alimohammadi, Mohammad; Punga, Tanel

Ingår i Journal of the Neurological Sciences, s. 90-96, 2015.

DOI för Disease specific signature of circulating miR-150-5p and miR-21-5p in myasthenia gravis patients Ladda ner fulltext (pdf) av Disease specific signature of circulating miR-150-5p and miR-21-5p in myasthenia gravis patients

Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis

Phillips, W D; Christadoss, P; Losen, M; Punga, Anna Rostedt et al.

Ingår i Experimental Neurology, s. 29-40, 2015.

DOI för Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis

How clinical trials of myasthenia gravis can inform pre-clinical drug development

Rostedt Punga, Anna; Kaminski, Henry J; Richman, David P; Benatar, Michael

Ingår i Experimental Neurology, s. 78-81, 2015.

DOI för How clinical trials of myasthenia gravis can inform pre-clinical drug development

Circulating miRNAs in myasthenia gravis: miR-150-5p as a new potential biomarker

Punga, Tanel; Le Panse, Rozen; Andersson, Mats; Truffault, Frédérique et al.

Ingår i Annals of clinical and translational neurology, s. 49-58, 2014.

DOI för Circulating miRNAs in myasthenia gravis: miR-150-5p as a new potential biomarker

Vitamin D deficiency in patients with primary immune-mediated peripheral neuropathies

Elf, Kristin; Askmark, Håkan; Nygren, Ingela; Punga, Anna Rostedt

Ingår i Journal of the Neurological Sciences, s. 184-188, 2014.

DOI för Vitamin D deficiency in patients with primary immune-mediated peripheral neuropathies

Correlation of Botulinum Toxin Dose with Neurophysiological Parameters of Efficacy and Safety in the Glabellar Muscles: A Double-blind, Placebo-controlled, Randomized Study

Alimohammadi, Mohammad; Andersson, Mats; Punga, Anna Rostedt

Ingår i Acta Dermato-Venereologica, s. 32-37, 2014.

DOI för Correlation of Botulinum Toxin Dose with Neurophysiological Parameters of Efficacy and Safety in the Glabellar Muscles: A Double-blind, Placebo-controlled, Randomized Study

Muscle-specific regulation of the mTOR signaling pathway in MuSK antibody seropositive (MuSK plus ) experimental autoimmune Myasthenia gravis (EAMG)

Chauhan, Mayank; Punga, Tanel; Punga, Anna Rostedt

Ingår i Neuroscience research, s. 102-109, 2013.

DOI för Muscle-specific regulation of the mTOR signaling pathway in MuSK antibody seropositive (MuSK plus ) experimental autoimmune Myasthenia gravis (EAMG)